Most Recent
Corrs Chambers nabs corporate partner from Gilbert + Tobin
Corrs Chambers Westgarth has lured a corporate lawyer who spent 14 years working at Gilbert + Tobin, its latest hire from the rival firm.
Construction PRO
Igneo Infrastructure acquires remaining stake in SA wind farm
Igneo Infrastructure's Australian renewable energy platform Atmos Renewables has acquired the remaining stake in the 316MW Hornsdale wind farm from Neoen Australia in a $400 million deal.
High Court to hear developer Mayfield’s appeal in case against NSW Ports
Mayfield Development has been granted the High Court's leave to make its argument that derivative Crown immunity does not apply to NSW Ports, in a seven-year-old competition case. 
Zuleika Gold waived privilege over report in fight over gold joint venture, judge says
Gold exploration company Zuleika Gold has to produce a draft technical report to Vango Mining as it seeks "significant damages' over a repudiated joint venture agreement, with a judge finding an affidavit from its solicitor put the report squarely in issue. 
Trial over Cosette’s termination of $672M Mayne Pharma merger delayed
Mayne Pharma and US drug maker Cosette have agreed to postpone the start of trial in a case over the termination of a $672 million merger to allow for late amendments.
Gilbert + Tobin’s head of corporate advisory to join Corrs Chambers Westgarth
Gilbert +Tobin’s executive partner and corporate advisory head Tim Gordon will join Corrs Chambers Westgarth’s corporate practice based after almost 20 years at G+T.
High Court shoots down solicitors’ CFO in Blue Sky class action
The High Court has unanimously found the Federal Court has no power to allow solicitors to take a cut of a settlement or judgment in a shareholder class action against Blue Sky, saying it would be contrary to rules against contingency fees in NSW. 
Construction PRO
Gilbert + Tobin beefs up real assets team with Blackstone hire
Gilbert + Tobin has strengthened its real assets team with the appointment of a partner recruited from global asset manager Blackstone.
Mayne denies continuous disclosure breaches in feud with Cosette
Mayne Pharma has denied US drug maker Cosette's claims it breached its continuous disclosure obligations in relation to US FDA concerns about marketing for its Nextstellis contraceptive, as the drug makers spar over their $672 million merger.
Mayne Pharma may face disclosure breach claim over $672M merger collapse
A court has heard US drug maker Cosette may amend its case to accuse Adelaide's Mayne Pharma of continuous disclosure breaches in their battle over the termination of their $672 million merger.